|
|
Volumn 122, Issue 5, 2009, Pages 407-408
|
|
Platelet Inhibition with Prasugrel and Increased Cancer Risks: Potential Causes and Implications
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
BIOLOGICAL MARKER;
CLOPIDOGREL;
PRASUGREL;
PROTEINASE ACTIVATED RECEPTOR 1;
THROMBOCYTE FACTOR 4;
BLEEDING;
CANCER RISK;
CELL ACTIVITY;
COLORECTAL TUMOR;
DRUG EFFICACY;
DRUG INHIBITION;
DRUG SAFETY;
EDITORIAL;
FIBRINOLYSIS;
FOLLOW UP;
HYPERCOAGULABILITY;
ISCHEMIA;
METASTASIS;
PATIENT CARE;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
THROMBOCYTE AGGREGATION INHIBITION;
THROMBOCYTE MEMBRANE;
THROMBOPHILIA;
THROMBOSIS;
TUMOR GROWTH;
BLOOD PLATELETS;
COLORECTAL NEOPLASMS;
FIBRINOLYSIS;
HUMANS;
INCIDENCE;
PIPERAZINES;
PLATELET AGGREGATION;
RECEPTORS, PURINERGIC P2;
RISK FACTORS;
THIOPHENES;
THROMBOSIS;
UNITED STATES;
|
|
EID: 64349100211
PISSN: 00029343
EISSN: None
Source Type: Journal
DOI: 10.1016/j.amjmed.2008.11.023 Document Type: Editorial |
|
Times cited : (40)
|
|
References (2)
|
